C62.1
Malignant neoplasm of descended testis
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of scrotal testis
Medical Intelligence & Overview
Malignant neoplasm of the descended testis, classified under ICD-10 code C62.1, refers to testicular cancer that originates in the testis which has descended into the scrotum. This type of cancer is a significant health concern predominantly affecting men, particularly in their younger and middle years. Early detection and treatment are crucial for favorable outcomes. This overview aims to explain the nature of this condition, its possible causes, common symptoms, methods of diagnosis, and available treatments.
Causes & Symptoms
Clinical Causes: Genetic factors, including family history of testicular cancer Undescended testis (cryptorchidism), which increases risk if not corrected early Personal history of testicular cancer in the opposite testis Certain genetic disorders and syndromes Environmental exposures to hazardous chemicals that may affect testicular health
Key Symptoms: A painless lump or swelling in the testicle A feeling of heaviness or aching in the scrotum or lower abdomen A sudden collection of fluid in the scrotum Unexplained pain or discomfort in the testicle or scrotum Enlargement of the testicle or a noticeable difference in size Feeling of fatigue or general malaise if the cancer has spread
Diagnostic & Treatment
Diagnosis Path: Diagnosing malignant neoplasm of the descended testis involves a combination of clinical evaluation and medical imaging. Common diagnostic steps include: - Physical examination to identify any lumps or abnormal swelling - Ultrasound imaging to assess the size, shape, and structure of the testicle - Blood tests measuring tumor markers such as alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and lactate dehydrogenase (LDH) - Biopsy, which is sometimes performed, although often surgical removal of the affected testis (orchiectomy) provides definitive diagnosis - Staging scans, including CT or PET scans, to determine if the cancer has spread beyond the testis
Treatment Protocols: Treatment options for malignant neoplasm of the descended testis depend on the stage and type of the tumor and may include: - Surgical removal of the affected testis (orchiectomy) - Removal of nearby lymph nodes if cancer has spread - Radiation therapy, mainly for certain types of testicular cancer - Chemotherapy to target remaining cancer cells, especially in advanced stages - Surveillance and regular follow-up to monitor for recurrence or metastasis Prognosis is generally favorable, especially if diagnosed early, with high cure rates for localized tumors. Multidisciplinary care ensures tailored treatment strategies to improve outcomes.
Clinical Advice & FAQs
Billing Guidance
Is C62.1 a billable ICD-10 code?
Yes, C62.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C62.1?
Clinical documentation must specify the nature of Malignant neoplasm of descended testis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference